By Olga Cotaga

LONDON--Reckitt Benckiser Group PLC (RB.LN) reported Friday a first-quarter revenue of 2.64 billion pounds ($3.31 billion), 15% up considering the foreign exchange rates.

Excluding the impact of changes in exchange rates, like-for-like revenue stayed unchanged, but the company backed its full-year guidance of 3% growth.

Revenue in the first three months of 2017 was helped by a good performance from the health unit, which offset the headwinds in the Scholl and Amopé unit.

The acquisition of Mead Johnson is on track and should be completed by the end of the third quarter, the company said.

Write to Olga Cotaga at olga.cotaga@wsj.com, Twitter @OlgaCotaga

(END) Dow Jones Newswires

April 21, 2017 02:28 ET (06:28 GMT)

Copyright (c) 2017 Dow Jones & Company, Inc.
Reckitt Benckiser (LSE:RKT)
Historical Stock Chart
From Mar 2024 to May 2024 Click Here for more Reckitt Benckiser Charts.
Reckitt Benckiser (LSE:RKT)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Reckitt Benckiser Charts.